Re: Farmas Orphan Drug
Row Num Generic Name Designation Date Orphan Designation Marketing Approval Date
1 Macitentan 09-03-2009 Pulmonary Arterial Hypertension 10-18-2013
2 Riociguat 09-19-2013 Chronic Thromboembolic Pulmonary Hypertension 10-08-2013
3 Riociguat 09-19-2013 Pulmonary Arterial Hypertension 10-08-2013
http://orphandruganaut.wordpress.com/2013/11/04/fda-october-2013-orphan-designations-receiving-approval/
The chart below identifies the 28 FDA October 2013 Products Receiving Orphan Designation. The chart is generated from the FDA’s Orphan Drug Product Designation Database Application and is current as of November 3, 2013. The chart is created by performing a search for the following date range:
http://orphandruganaut.wordpress.com/2013/11/03/fda-october-2013-products-receiving-orphan-designation/